Health Trials

Platinum Resistant High Grade Epithelial Ovarian Primary Peritoneal Or Fallopian Tube Cancers Hgsoc

1

Review clinical trials related to Platinum Resistant High Grade Epithelial Ovarian Primary Peritoneal Or Fallopian Tube Cancers Hgsoc. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

The primary purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of GTAEXS617 (REC-617) in participants with advanced solid tumors.

Participants needed: 230
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.Updated: Apr 23, 2026Locations: 13
Eligibility criteria

Eastern Cooperative Oncology Group (ECOG) performance status 0-1. [+5]

Active and clinically significant (CS) infection. [+11]

Read more